Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Core-modified sordaricin derivatives: synthesis and antifungal activity.
Regueiro-Ren A, Carroll TM, Chen Y, Matson JA, Huang S, Mazzucco CE, Stickle TM, Vyas DM, Balasubramanian BN. Regueiro-Ren A, et al. Among authors: vyas dm. Bioorg Med Chem Lett. 2002 Dec 2;12(23):3403-5. doi: 10.1016/s0960-894x(02)00764-3. Bioorg Med Chem Lett. 2002. PMID: 12419371
Oxime derivatives of sordaricin as potent antifungal agents.
Serrano-Wu MH, St Laurent DR, Mazzucco CE, Stickle TM, Barrett JF, Vyas DM, Balasubramanian BN. Serrano-Wu MH, et al. Among authors: vyas dm. Bioorg Med Chem Lett. 2002 Mar 25;12(6):943-6. doi: 10.1016/s0960-894x(02)00054-9. Bioorg Med Chem Lett. 2002. PMID: 11958999
Sordarin oxazepine derivatives as potent antifungal agents.
Serrano-Wu MH, St Laurent DR, Chen Y, Huang S, Lam KR, Matson JA, Mazzucco CE, Stickle TM, Tully TP, Wong HS, Vyas DM, Balasubramanian BN. Serrano-Wu MH, et al. Among authors: vyas dm. Bioorg Med Chem Lett. 2002 Oct 7;12(19):2757-60. doi: 10.1016/s0960-894x(02)00529-2. Bioorg Med Chem Lett. 2002. PMID: 12217370
Sordaricin antifungal agents.
Quesnelle CA, Gill P, Dodier M, St Laurent D, Serrano-Wu M, Marinier A, Martel A, Mazzucco CE, Stickle TM, Barrett JF, Vyas DM, Balasubramanian BN. Quesnelle CA, et al. Among authors: vyas dm. Bioorg Med Chem Lett. 2003 Feb 10;13(3):519-24. doi: 10.1016/s0960-894x(02)00937-x. Bioorg Med Chem Lett. 2003. PMID: 12565963
Identification of a broad-spectrum azasordarin with improved pharmacokinetic properties.
Serrano-Wu MH, Laurent DR, Carroll TM, Dodier M, Gao Q, Gill P, Quesnelle C, Marinier A, Mazzucco CE, Regueiro-Ren A, Stickle TM, Wu D, Yang H, Yang Z, Zheng M, Zoeckler ME, Vyas DM, Balasubramanian BN. Serrano-Wu MH, et al. Among authors: vyas dm. Bioorg Med Chem Lett. 2003 Apr 17;13(8):1419-23. doi: 10.1016/s0960-894x(03)00161-6. Bioorg Med Chem Lett. 2003. PMID: 12668003
Synthesis of a novel C-10 spiro-epoxide of paclitaxel.
Walker MA, Johnson TD, Huang S, Vyas DM, Kadow JF. Walker MA, et al. Among authors: vyas dm. Bioorg Med Chem Lett. 2001 Jul 9;11(13):1683-5. doi: 10.1016/s0960-894x(01)00280-3. Bioorg Med Chem Lett. 2001. PMID: 11425537
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R).
Velaparthi U, Wittman M, Liu P, Stoffan K, Zimmermann K, Sang X, Carboni J, Li A, Attar R, Gottardis M, Greer A, Chang CY, Jacobsen BL, Sack JS, Sun Y, Langley DR, Balasubramanian B, Vyas D. Velaparthi U, et al. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2317-21. doi: 10.1016/j.bmcl.2007.01.102. Epub 2007 Feb 4. Bioorg Med Chem Lett. 2007. PMID: 17317169
Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile.
Velaparthi U, Liu P, Balasubramanian B, Carboni J, Attar R, Gottardis M, Li A, Greer A, Zoeckler M, Wittman MD, Vyas D. Velaparthi U, et al. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3072-6. doi: 10.1016/j.bmcl.2007.03.048. Epub 2007 Mar 19. Bioorg Med Chem Lett. 2007. PMID: 17398093
Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model.
Balasubramanian BN, St Laurent DR, Saulnier MG, Long BH, Bachand C, Beaulieu F, Clarke W, Deshpande M, Eummer J, Fairchild CR, Frennesson DB, Kramer R, Lee FY, Mahler M, Martel A, Naidu BN, Rose WC, Russell J, Ruediger E, Solomon C, Stoffan KM, Wong H, Wright JJ, Zimmermann K, Vyas DM. Balasubramanian BN, et al. Among authors: vyas dm. J Med Chem. 2004 Mar 25;47(7):1609-12. doi: 10.1021/jm034197s. J Med Chem. 2004. PMID: 15027851
58 results